NCT04849312View on ClinicalTrials.gov

Prediction of 30-Day Readmission Using Machine Learning

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 20, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
InfectionHeart FailureChronic Obstructive Pulmonary DiseaseAsthmaGout FlareChronic Kidney DiseasesHypertensive UrgencyAtrial Fibrillation RapidAnticoagulants; Increased
Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

02130

Brigham and Women's Faulkner Hospital, Boston

Sponsors

Collaborators (1)

Biofourmis Inc.
All Listed Sponsors
collaborator

Biofourmis Inc.

INDUSTRY

lead

Brigham and Women's Hospital

OTHER